← Leaderboards
Alexey V Terskikh
Burnham Institute For Medical Research
$9,383,736
Attributed
$12,403,638
Total exposure
15
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,403,638 · 15
By mechanism
R21$6,365,948 · 11
R01$5,373,428 · 2
R42$350,000 · 1
R41$314,262 · 1
Top collaborators
- Alysson R. Muotri5 shared
- Steven H Olson5 shared
- Sujan Shresta2 shared
- Alex Y Strongin2 shared
- Brian Stanley Egan1 shared
- Alex Groisman1 shared
- Mary Anne Jelinek1 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIn VivoBrainLaboratoriesNerve Stem CellMolecularBaseEpigenetic ProcessBiologicalMachine LearningAnimalsStemLinkAffectCell TypeLifePatternMouse ModelValidationIn VitroStem CellsMicroscopic ImagingSmall MoleculeLead
Grant awards (35)
Arrays of bottomless picowells for the analysis of biological age using high-resolution imaging$498,366
R21 · FY2025 · AG
Novel imaging-based platform for cell quality and identity control$350,000
R42 · FY2025 · GM · contact PI
Testing energy expenditures as biomarkers of aging using thermal imaging in a controlled environment$529,650
R21 · FY2024 · AG · contact PI
Testing the utility of miBioAge as a personalized aging biomarker$509,750
R21 · FY2024 · AG · contact PI
Novel Integrated Platform to Quantitate Rejuvenation in vivo$314,262
R41 · FY2024 · AG
Brain pathology and function in a chronic mouse model of ZIKV transmission$654,901
R01 · FY2023 · NS · contact PI
Testing the utility of miBioAge as a personalized aging biomarker$399,786
R21 · FY2023 · AG · contact PI
Novel Strategy to Quantitate Delayed Aging by Caloric Restriction$250,212
R21 · FY2023 · AG · contact PI
Testing the utility of miBioAge as a personalized aging biomarker$170,000
R21 · FY2023 · AG · contact PI
Brain pathology and function in a chronic mouse model of ZIKV transmission$655,064
R01 · FY2022 · NS · contact PI
Novel Strategy to Quantitate Delayed Aging by Caloric Restriction$410,886
R21 · FY2022 · AG · contact PI
Novel Strategy to Quantitate Delayed Aging by Caloric Restriction$298,728
R21 · FY2022 · AG · contact PI
Role of Epigenetically Active Environmental Compounds in Neurodevelopmental Disorders$195,000
R21 · FY2022 · ES · contact PI
Brain pathology and function in a chronic mouse model of ZIKV transmission$655,075
R01 · FY2021 · NS · contact PI
Role of Epigenetically Active Environmental Compounds in Neurodevelopmental Disorders$243,750
R21 · FY2021 · ES · contact PI
Phenotypic Screening for Longevity Interventions Using Single-cell Epigenetic Signatures$243,750
R21 · FY2021 · AG · contact PI
Role of Epigenetically Active Environmental Compounds in Neurodevelopmental Disorders$195,000
R21 · FY2021 · ES · contact PI
Brain pathology and function in a chronic mouse model of ZIKV transmission$654,787
R01 · FY2020 · NS · contact PI
Phenotypic Screening for Longevity Interventions Using Single-cell Epigenetic Signatures$292,500
R21 · FY2020 · AG · contact PI
Role of Epigenetically Active Environmental Compounds in Neurodevelopmental Disorders$292,500
R21 · FY2020 · ES · contact PI
Brain pathology and function in a chronic mouse model of ZIKV transmission$678,490
R01 · FY2019 · NS · contact PI
Host-pathogen interactions in ZIKV infection leading to microcephaly$236,250
R21 · FY2017 · NS
Host-pathogen interactions in ZIKV infection leading to microcephaly$307,250
R21 · FY2016 · NS
Role of MELK in glioblastomas$403,410
R01 · FY2014 · NS · contact PI
Role of MELK in glioblastomas$393,223
R01 · FY2013 · NS · contact PI
Role of MELK in glioblastomas$399,939
R01 · FY2012 · NS · contact PI
Role of MELK in glioblastomas$399,939
R01 · FY2011 · NS · contact PI
Role of MELK in glioblastomas$430,850
R01 · FY2010 · NS · contact PI
Role of MELK in glioblastomas$47,750
R01 · FY2010 · NS · contact PI
MELK as Functional Marker for Mammary Tumors$214,875
R21 · FY2009 · CA · contact PI
MELK as Functional Marker for Mammary Tumors$257,850
R21 · FY2008 · CA · contact PI
Protein Acetylation Signature of ES Cell Differentiation$208,645
R21 · FY2007 · HD · contact PI
Protein Acetylation Signature of ES Cell Differentiation$257,850
R21 · FY2006 · HD · contact PI
Separation of Stem Cells From Differentiated Cells$176,675
R21 · FY2005 · NS
Separation of Stem Cells From Differentiated Cells$176,675
R21 · FY2004 · NS